Tevogen (TVGN) Restructuring Costs (2024)
Tevogen Bio Holdings' (TVGN) quarterly Restructuring Costs came in at $7.5 million in Q1 2024.
Tevogen (TVGN) Restructuring Costs (2024) Analysis & Trends
Tevogen Bio Holdings (TVGN) has 1 years of Restructuring Costs data on file, last reported at $7.5 million in Q1 2024.
- Quarterly Restructuring Costs changed N/A year-over-year to $7.5 million in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $7.5 million (changed N/A YoY) and the FY2024 annual result came in at $7.5 million, changed N/A from the prior year.
- Restructuring Costs steadied at $7.5 million in Q1 2024.
- In the past five years, Restructuring Costs ranged from a high of $7.5 million in Q1 2024 to a low of $7.5 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.39 Bn | 132.54 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.47 Bn | 78.47 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 61.79 Bn | 56.66 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.27 Bn | 37.17 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.17 Bn | 27.86 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.61 Bn | 10.22 Bn | 668.28 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - |
| 10 | Tevogen | 27.32 Mn | 27.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 7.50 Mn |